Voorbeelden van het gebruik van Measures regulating in het Engels en hun vertalingen in het Nederlands
{-}
-
Official
-
Colloquial
-
Ecclesiastic
-
Medicine
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Transparency of measures regulating the prices of medicinal products for human use.
Both sides agreed to oppose all forms of protectionist measures regulating trade.
Medicinal products for human use/ transparency of measures regulating their prices/ their inclusion in the scope of public health insurance systems.
It welcomed the linkage with the European Refugee Fund and the fact that the directive included measures regulating the return home.
Transparency of measures regulating the prices of me dicinal products for human use Austria nuclear safety and civil.
limitations of the maximum speed or measures regulating the access to certain roads.
Transparency of measures regulating the pricing of medicinal products for human use
to launch new measures regulating financial services in the European Union.
Proposal for a DIRECTIVE relating to the transparency of measures regulating the prices of medicinal products for human use
examining the application of Council Directive 89/105/EEC relating to the transparency of measures regulating the prices of medicinal products for human use
Directive 89/105/EEC relates to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of national health insurance systems.
on the proposal for a Directive relating to the transparency of measures regulating the pricing of medicinal products for human use
A directive on the transparency of measures regulating the pricing of medicinal products for human use
of the Council on the transparency of measures regulating the prices of medicinal products for human use
The Commission is drawing up a set of economic measures regulating infrastructures to favour greater use of those transport modes that still have available capacity
of the Council relating to the transparency of measures regulating the prices of medicinal products for human use
Measures regulating fisheries management can only be taken in the context of the Common Fisheries Policy,
The object of Directive 89/105 1 is to ensure the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of national health insurance systems.
of the Council relating to the transparency of measures regulating the prices of medicinal products for human use
Council Directive 89/105/EEC relating to the transparency of measures regulating the pricing of medicinal products for human use
Failure of a Member State to fulfil obligations- Infringement of Article 6(1) of Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the pricing of medicinal products for human use
Revision of the Directive relating to transparency of measures regulating the pricing of medicinal products for human use
Recommendation for the second reading(PE A 2-234/88) concerning the common position of the Council on a proposal for.a directive relating to the transparency of measures regulating the pricing of medicinal products for human use
Review of Council Directive 89/105/EEC relating to the transparency of measures regulating the pricing of medicinal products for human use
The Cyprus presidency informed the Council on the state of play in the negotiations on a draft directive relating to the transparency of measures regulating to the pricing of medicinal products for human use
Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the pricing of medicinal products for human use
on 21 December 1988 relating to the transparency of measures regulating the pricing of medicinal products for human use
A Committee called the'Consultative Committee for the implementation of Directive 89/105/EEC relating to the transparency of measures regulating the pricing of medicinal produas for human use
A Committee called the'Consultative Committee for the implementation of Directive 89/105/EEC relating to the transparency of measures regulating the pricing of medicinal products for human use and their inclusion in the scope of national health insurance systems' shall be set up and attached to the Commission.
if only because of the prohibitive cost, the argument that simply fixing an MRL for betaagonists makes the adoption of any other measure regulating their use unnecessary must be rejected.